IP Library › Assignment 042928/0668
Patent Assignment
Reel/Frame 042928/0668

First Amendment to Intellectual Property Security Agreement

Recorded: 2017-06-21 Pages: 9
Assignor
CANCER GENETICS, INC.
Executed: 2017-06-16
Assignee
SILICON VALLEY BANK
275 GROVE STREET, SUITE 2-200, NEWTON, MASSACHUSETTS, 02466
Covered Properties (31)
Systems and methods for analyzing gene expression data for clinical diagnostics
Application: 10/861,216 →
Publication: US 2005/0069863
Systems and Methods for Detecting Biological Features
Application: 10/954,443 →
Publication: US 2005/0071087
Systems and Methods for Phenotypic Classification Using Biological Samples of Different Sample Types
Application: 12/705,443 →
KRAS Primers and Probes
Application: 13/640,416 →
Publication: US 2013/0029336
Kras Primers and Probes
Application: 14/570,771 →
Publication: US 2015/0184250
Systems and Methods for Detecting Biological Features
Application: 14/624,453 →
Publication: US 2015/0161327
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 Expression
Patent: 6,518,416 →
Application: 09/796,491 →
Method of Determining Dihydropyrimidine Dehydrogenase Gene Expression
Patent: 6,956,111 →
Application: 09/796,807 →
Publication: US 2002/0123620
Method of Determining Dihydropyrimidine Dehydrogenase Gene Expression
Patent: 6,905,821 →
Application: 09/842,111 →
Publication: US 2002/0164597
Method of Determining a Chemotherapeutic Regimen Based on Ercci Expression
Patent: 6,573,052 →
Application: 09/877,095 →
Publication: US 2002/0123051
Method of Determining Epidermal Growth Factor Receptor and HER2-Neu Gene Expression and Correlation of Levels Thereof with Survival Rates
Patent: 6,582,919 →
Application: 09/877,177 →
Publication: US 2002/0192652
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and Ts Expression
Patent: 7,049,059 →
Application: 09/877,178 →
Publication: US 2004/0009475
Method of Determining Dihydropyrimidine Dehydrogenase Gene Expression
Patent: 7,005,278 →
Application: 09/879,217 →
Publication: US 2003/0165840
Method of Determining a Chemotherapeutic Regimen Based on Glutathione-S-Transferase Pi Expression
Patent: 6,686,155 →
Application: 09/879,986 →
Publication: US 2002/0197609
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 Expression
Patent: 6,602,670 →
Application: 09/988,784 →
Publication: US 2002/0086315
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 Expression
Patent: 7,132,238 →
Application: 10/453,784 →
Publication: US 2004/0005621
Method of Determining a Chemotherapeutic Regimen Based on Glutathione-S Transferase Pi Expression
Patent: 7,138,507 →
Application: 10/654,575 →
Publication: US 2005/0019783
Knowledge-Based Storage of Diagnostic Models
Patent: 8,321,137 →
Application: 10/861,177 →
Publication: US 2005/0071143
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and Ts Expression
Patent: 7,560,543 →
Application: 11/341,515 →
Publication: US 2006/0121526
Method of Determining a Chemotherapeutic Regimen by Assaying Gene Expression in Primary Tumors
Patent: 8,026,062 →
Application: 11/731,128 →
Publication: US 2008/0160517
Systems and Methods for Diagnosing a Biological Specimen Using Probabilities
Patent: 7,747,547 →
Application: 12/378,165 →
A Method and System for Standardization of Microarray Data
Patent: 8,473,217 →
Application: 12/378,187 →
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and Ts Expression
Patent: 7,732,144 →
Application: 12/502,753 →
Publication: US 2009/0311708
Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression
Patent: 8,586,311 →
Application: 12/774,261 →
Publication: US 2011/0212981
Methods, Primers, Probes and Kits Useful for the Detection of BRAF Mutations
Patent: 8,728,763 →
Application: 12/853,746 →
Publication: US 2011/0269124
Systems and Methods for Detecting Biological Features
Patent: 8,977,506 →
Application: 13/418,991 →
Publication: US 2012/0215514
HER3 and HER4 Primers and Probes for Detecting HER3 and HER4 Mrna Expression
Method of Determining a Chemotherapeutic Regimen Based on Loss of Herterozygosity at the Thymidylate Synthase Locus
Methods, Primers, Probes and Kits Useful for the Detection of Braf Mutations
Primers, Probes, Methods and Kits for the Detection of EML4-Alk Variants
A Novel EML4-Alk Variant: Primers, Probes, Methods, and Kits for the Detection Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0487 →
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0447 →
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0540 →
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0426 →
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0472 →
Assignment of Assignor's Interest Aug 3, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012086/0461 →
Assignment of Assignor's Interest Aug 20, 2001
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 012108/0364 →
Assignment of Assignor's Interest Nov 20, 2001
From: DANENBERG, KATHLEEN D.
To: RESPONSE GENETICS, INC.
Reel/Frame 012340/0300 →
Assignment of Assignor's Interest Oct 26, 2004
From: MORALEDA, JORGE; ANDERSON, GLENDA G.
To: PATHWORK INFORMATICS, INC.
Reel/Frame 015924/0346 →
Assignment of Assignor's Interest Oct 26, 2004
From: TRAN, QUANG; ANDERSON, GLENDA G.; PATTIN, ALEJANDRINA; HORNBAKER, CHERYL
To: PATHWORK INFORMATICS, INC.
Reel/Frame 015924/0423 →
Assignment of Assignor's Interest Jan 11, 2005
From: ANDERSON, GLENDA G.
To: PATHWORK INFORMATICS, INC.
Reel/Frame 016147/0607 →
Certificate of Ownership and Merger and Certificate of Amendment of Predicant Biosciences Inc. Jan 26, 2007
From: PATHWORK INFORMATICS, INC.
To: PATHWORK DIAGNOSTICS, INC.
Reel/Frame 018843/0239 →
Assignment of Assignor's Interest Jul 1, 2010
From: BUTUROVIC, LJUBOMIR J.; TADAKAMALLA, RAJESWARI PILLAI
To: PATHWORK DIAGNOSTICS, INC.
Reel/Frame 024627/0236 →
Assignment of Assignor's Interest Mar 6, 2011
From: DANENBERG, KATHLEEN
To: RESPONSE GENETICS, INC.
Reel/Frame 025906/0695 →
Assignment of Assignor's Interest Oct 22, 2012
From: STEPHENS, CRAIG
To: RESPONSE GENETICS, INC.
Reel/Frame 029164/0526 →
Security Agreement Dec 11, 2012
From: PATHWORK DIAGNOSTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 029449/0797 →
Assignment of Assignor's Interest Nov 15, 2013
From: PATHWORK DIAGNOSTICS, INC.
To: RESPONSE GENETICS, INC.
Reel/Frame 031615/0088 →
Security Interest Jan 29, 2015
From: RESPONSE GENETICS, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 034848/0647 →
Certificate of Ownership and Merger; and Certificate of Amendment of Predicant Biosciences, Inc. May 7, 2015
From: PATHWORK INFORMATICS, INC.
To: PATHWORK DIAGNOSTICS, INC.
Reel/Frame 035614/0315 →
Assignment of Assignor's Interest May 7, 2015
From: PATHWORK DIAGNOSTICS, INC.
To: RESPONSE GENECTICS, INC.
Reel/Frame 035591/0074 →
Assignment of Assignor's Interest May 7, 2015
From: ANDERSON, GLENDA G.
To: PATHWORK INFORMATICS, INC.
Reel/Frame 035590/0869 →
Security Interest May 1, 2017
From: CANCER GENETICS, INC.
To: PARTNERS FOR GROWTH V, L.P.
Reel/Frame 042192/0126 →
Assignment of Assignor's Interest May 5, 2017
From: RESPONSE GENETICS, INC.
To: CANCER GENETICS, INC.
Reel/Frame 042257/0576 →
Assignment of Assignor's Interest Apr 19, 2018
From: RESPONSE GENETICS, INC.
To: CANCER GENETICS, INC.
Reel/Frame 045589/0842 →
Release of Intellectual Property Security Agreement Jul 16, 2019
From: PARTNERS FOR GROWTH IV, L.P.
To: CANCER GENETICS, INC.
Reel/Frame 049771/0446 →